Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center
暂无分享,去创建一个
G. Song | Sung‐Gyu Lee | D. Jung | Shin Hwang | C. Ahn | Ki‐Hun Kim | D. Moon | T. Ha | G. Park | H. Ha | J. Hong | I. Kim | I. Jeong
[1] G. Song,et al. A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asan Medical Center: Increased preference for mycophenolate mofetil , 2018, Annals of hepato-biliary-pancreatic surgery.
[2] H. Wang,et al. A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B , 2017, Annals of transplantation.
[3] J. Yeon,et al. KASL clinical practice guidelines: management of chronic hepatitis B , 2016, Clinical and molecular hepatology.
[4] F. Nevens,et al. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin , 2015, Transplantation.
[5] Xiaoshun He,et al. Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis , 2014, PloS one.
[6] G. Song,et al. Toward more than 400 liver transplantations a year at a single center. , 2013, Transplantation proceedings.
[7] H. Yim,et al. KASL Clinical Practice Guidelines: Management of chronic hepatitis B , 2012, Clinical and molecular hepatology.
[8] G. Song,et al. Safety of ultra-rapid intravenous infusion of hepatitis B immunoglobulin in liver transplant recipients. , 2011, Transplantation Proceedings.
[9] J. Yang,et al. Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low‐Dose Hepatitis B Immunoglobulin , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] Jörg Petersen,et al. EASL Clinical Practice Guidelines: management of chronic hepatitis B. , 2009, Journal of hepatology.
[11] G. Song,et al. Prevention of hepatitis B recurrence after living donor liver transplantation: Primary high‐dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] U. Aydin,et al. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis , 2007, Journal of gastroenterology and hepatology.
[13] P. Angus,et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. , 2007, Gastroenterology.
[14] D. Samuel,et al. Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] S. Cotler,et al. Management of hepatitis B in liver transplant patients. , 2005, Journal of clinical gastroenterology.
[16] D. Samuel,et al. Evolving strategies to prevent HBV recurrence , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] A. Lok,et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.